Chief Operating Officer
CurrentECI provides a range of flexible and comprehensive services to the pharmaceutical, bio tech, medical device and related industries. Whereas most compliance advisory firms are engaged post-M & A, ECI is the is actively involved in pre-M & A audits, focused on managing the due diligence process up front and helping the buying client to better understand the valuation of the M&A.As chief executive officer, Shital is responsible for overall program management, establishing corporate policy, and running the day-to-day operations of the firm. She is intimately involved in solution design, consultant performance, business development, client relationship management, and new product launches (systems, software, and organizational tools).The firm’s core services assure that client products follow FDA or global government standards and meet regulations, along with ensuring quality, efficacy and safety in bringing to market innovative life-changing – even life-saving – advancements in the life sciences field, and include:♦ Non-Compliance Remediation♦ Regulatory Compliance♦ Program Management♦ Manufacturing♦ Research & Development♦ ValidationFor more information, please visit http://www.eci-rx.com/Shital is interested in connecting with managers, directors, and VPs in the life sciences (pharmaceutical, biotech, medical device, nutritionals) industries, who are responsible for operations, quality, compliance, and new product development, as well as directors of quality or compliance. For prompt response, please contact Shital at Shital.Patel@eci-rx.com.
